SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

UPDATE: Goldman Maintains Buy On Incyte, Lowers Target To $107, Keeps On Americas Conviction List Notes 'Ph3 GRAVITAS-301 fails; Looking to atopic dermatitis in 1H20'

Benzinga · -